Medical Research Commercialisation initiative
The Medical Research Commercialisation initiative supports innovative early stage health and medical research in Australia. It helps researchers transform their ideas into life-saving medicines, devices and treatments to help tomorrow’s patients.
What is the Medical Research Commercialisation initiative?
This initiative incorporates 2 activities under the Medical Research Future Fund:
- Biomedical Translation Bridge, which funds and nurtures early-stage health and medical research to reach proof-of-concept with the potential to attract further capital and support. Research will have secured at least matched funding from third-party sponsorship or co-investment.
- BioMedTech Horizons, which funds innovative and collaborative health technologies. It drives discoveries that address key health challenges towards proof-of-concept and commercialisation, maximising entrepreneurship and idea potential.
It will provide $311.3 million over 10 years.
Why is the Medical Research Commercialisation initiative important?
It’s hard to turn a scientific discovery into a medical product that’s ready for clinical use. Taking a project from an idea to a final product is a long and expensive process.
This initiative is important because it develops Australia’s world-class research into real treatments, drugs and devices to benefit Australians.
What are the goals of the Medical Research Commercialisation initiative?
The Medical Research Commercialisation initiative aims to support early-stage health and medical research and innovation in Australia through to proof-of-concept and beyond, providing opportunities for commercialisation.
How will we meet these goals?
See the initiative snapshot for details of how we plan to meet these goals.
MRFF snapshot – Medical Research Commercialisation
This snapshot shows this initiative at a glance. It includes budgets, early funding priorities and grant timelines, as at November 2019. Researchers and other stakeholders can use it to plan for upcoming opportunities and see how the initiative will be established, expanded and embedded over time.
Who works with us on the Medical Research Commercialisation initiative?
The Medical Research Future Fund (MRFF) funds the initiative.
Our Health and Medical Research Office oversees this and other MRFF initiatives.
MTPConnect administers the Biomedical Translation Bridge and BioMedTech Horizons initiatives.
Apply for funding
We list all MRFF grants on GrantConnect when they open. If you want GrantConnect to notify you about future medical research commercialisation grants:
- register with them
- enter ‘MRFF’ in the keyword section of your GrantConnect profile
Status
Upcoming grants
We expect that additional rounds for the Biomedical Translation Bridge activity will occur in early 2020.
Open grant rounds
Applications for funding support under BioMedTech Horizons Round 3 administered by MTPConnect are open until Monday 16 December 2019.
Grants being assessed
No grants are currently being assessed.
Grants awarded
We have funded the following projects under this initiative, as at 30 September 2019.
|
Funded Institution |
Project Name |
Chief Investigator |
Total Funding |
|
MTPConnect |
Biomedical Translation Bridge |
Not applicable |
$22,300,000 |
|
MTPConnect |
BioMedTech Horizons Program (Rd 1) |
Not applicable |
$10,000,000 |
|
MTPConnect |
BioMedTech Horizons Program (Rd 2 & 3) |
Not applicable |
$35,000,000 |
|
Total |
|
$67,300,000 |
|
Related information
See a list of all MRFF grant recipients.
Contact
For more information contact MTPConnect.
Medical Research Future Fund (MRFF) contact
Contact for more information about the Medical Research Future Fund (MRFF), or to provide feedback on the MRFF website.
MTPConnect contact
MTPConnect is administering the Biomedical Translation Bridge and BioMedTech Horizons initiatives. Contact MTPConnect during business hours for information about these initiatives (funded by the Medical Research Future Fund).